DiagnaMed Unveils First Commercial AI Product For Healthcare Industry, FormGPT

DiagnaMed Holdings (CSE: DMED) has launched its first commercial product under its initiative to bring artificial intelligence to the healthcare industry. The initiative is currently focused on using AI to improve patient outcomes, operational workflow, and efficiency within the industry.

Read more